NCT/Study#
NCT04943900 /
CA102-003
Phase 1 Study Of BMS-986416 (TGF-B Inhibitor) Alone And In Combination With Nivolumab In Advanced Malignant Tumors.
DISEASE GROUP:
Phase 1 Clinical Trials
current phase:
Phase I
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information:
Call 201-518-3587
